Leadership

Home / About Us
Executive Management
The chief leaders are renowned professionals with deep experience in the medical device field. They lead an accomplished and dedicated team of R&D, operational, quality, marketing and regulatory professionals. Our medical and business advisory group is comprised of highly experienced clinicians, corporate, financial, legal and IP resource experts.

William H. Markle

President & CEO
William (Bill) Markle is President and CEO of GlySens. Mr. Markle has a 30-year track record of successful product and global market development, clinical evaluation, and visionary leadership in the medical device field. He was formerly founder, President, and CEO of GluMetrics, Inc. At GluMetrics, he directed the successful development of continuous real-time sensing technology for intravascular glucose monitoring in the intensive care and operating room environment. Previously, he held senior executive positions in marketing and business development at Tensys Medical and Masimo Corporation, and related positions at Baxter Edwards Critical Care and American Hospital Supply. Mr. Markle is an MBA graduate of Pepperdine University and an engineering graduate of Duke University. He is a named inventor on numerous issued U.S. patents and published applications.
Tim L. Routh
Vice President, Product Development
Sandra Martha, MS
Vice President, Clinical Affairs 

Don Healy
Vice President, Manufacturing

Ted Williams
Vice President, Regulatory Affairs & Quality Assurance

Medical Advisors

Bruce Buckingham, MD

Dr. Bruce Buckingham received his medical degree from University of California at San Diego. He completed his internship, residency, and fellowship at Children’s Hospital of Los Angeles. He is currently a Professor in the Department of Pediatric Endocrinology at Stanford Medical Center and the Stanford Children’s Hospital. His research focuses on continuous glucose monitoring in children and closed-loop (artificial pancreas) systems. He has collaborated on various overnight and 24-hour closed-loop platforms in development and has helped to develop algorithms for detecting infusion set and sensor failures and to improve infusion set wear duration.
Dr. Buckingham is well recognized as a leading expert in the real-world application and clinical use of continuous glucose monitoring systems.

Daniel Einhorn, MD

Dr. Daniel Einhorn is medical director of the Scripps Whittier Diabetes Institute, clinical professor of medicine (voluntary) at UC San Diego, president of Diabetes and Endocrine Associates, and associate editor of the Journal of Diabetes. He is a trustee and past-president of the American College of Endocrinology (ACE), a founding member and regent of the ACE Foundation, and past-president of the American Association of Clinical Endocrinologists (AACE). He received his BA at Yale (Summa cum Laude), his MD at Tufts (AOA) and his post-graduate training at Harvard. He has been in a leadership position in endocrinology for over 20 years during which time he has had the privilege of co-writing many national guidelines, including those for diabetes, pre-diabetes, inpatient diabetes management, and obesity, as well as leading consensus conferences on insulin resistance, pre-diabetes, obesity, and glucose monitoring. He has won the highest awards from AACE, ACE, and the Endocrine Society as well as numerous other honors. He has been on hundreds of teaching programs, written dozens of papers and chapters on diabetes, served on many dozens of scientific advisory committees, and has participated in clinical research on virtually all classes of diabetes therapies and diagnostics. He continues to be a practicing physician who loves seeing patients and their families and who appreciates the real world education he gets from them every day.

Board of Directors

Daniel P. Connally, CFA, Principal, Fayez Sarofim & Co.

Robert L. Engler, MD, Professor of Medicine, Emeritus, University of California, San Diego

Adam E. Fine, MBA, Founder and Managing Partner, Windham Venture Partners

Orville G. Kolterman, MD, Clinical & Regulatory Expert, former CMO, Amylin Pharmaceuticals, Inc.

William H. Markle, President and CEO, GlySens Incorporated

R. Cary McNair, Chairman and CEO, McNair Interests

Richard P. Thompson, Diabetes Entrepreneur and past President and CEO of ReShape Medical, Inc.

3931 Sorrento Valley Blvd
Suite 110
San Diego, CA 92121

Ph:  +1 (858) 638-7708
Fax: +1 (858) 638-7727

© 2020 GlySens Incorporated. All Rights Reserved.
CAUTION - Investigational device. Limited by Federal (or United States) law to investigational use.
GlySens®, Eclipse®, and ICGM® are trademarks of GlySens Incorporated registered in the U.S. Patent and Trademark Office.
Terms of UsePrivacy Policy
map-markerphoneuser-md linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram